Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Mol Cell Biol 26:47014711
Treatment adjustments may be considered if symptoms interfere with daily activities
It is characterized by delayed gastrointestinal motility, leading to increased hospital stay and longer recovery times
Long COVID patients consistently show: 13 Persistent gut dysbiosis with reduced microbial diversity lasting months after infection Depletion of butyrate-producing bacteria leading to reduced SCFA production and impaired immune regulation SARS-CoV-2mediated ACE2 downregulation disrupting renin-angiotensin system (RAS) balance and gut microbial homeostasis Increased intestinal permeability allowing endotoxin (LPS) translocation and systemic cytokine activation Gutorgan axis disruption contributing to respiratory, neurologic, cardiovascular, renal, and musculoskeletal symptoms Some studies have identified persistent viral RNA in gut tissue, suggesting the gastrointestinal tract may serve as a viral reservoir
US$ 22.35
US$ 23.19
US$ 23.79
